{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T07:06:48Z","timestamp":1769152008246,"version":"3.49.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T00:00:00Z","timestamp":1717372800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T00:00:00Z","timestamp":1717372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-024-03537-x","type":"journal-article","created":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T20:13:36Z","timestamp":1717445616000},"page":"3150-3168","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["LC\u2013MS metabolomics analysis of serum metabolites during neoadjuvant chemoradiotherapy in locally advanced rectal cancer"],"prefix":"10.1007","volume":"26","author":[{"given":"Qiliang","family":"Peng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0952-7517","authenticated-orcid":false,"given":"Yaqun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuntian","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,3]]},"reference":[{"issue":"3","key":"3537_CR1","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3322\/caac.21772","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023;73(3):233\u201354.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"3537_CR2","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41575-022-00736-1","volume":"20","author":"H Bando","year":"2023","unstructured":"Bando H, Ohtsu A, Yoshino T. Therapeutic landscape and future direction of metastatic colorectal cancer. Nat Rev Gastroenterol Hepatol. 2023;20(5):306\u201322.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"3537_CR3","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.annonc.2022.12.010","volume":"34","author":"L Xie","year":"2023","unstructured":"Xie L, Chen Q, Zhu J. The role of chemoradiotherapy in organ preservation for rectal cancer. Ann Oncol. 2023;34(4):440.","journal-title":"Ann Oncol"},{"issue":"4","key":"3537_CR4","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3322\/caac.21670","volume":"71","author":"DR Schmidt","year":"2021","unstructured":"Schmidt DR, Patel R, Kirsch DG, Lewis CA, Vander Heiden MG, Locasale JW. Metabolomics in cancer research and emerging applications in clinical oncology. CA Cancer J Clin. 2021;71(4):333\u201358.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"3537_CR5","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1093\/bib\/bbx170","volume":"20","author":"RK Azad","year":"2019","unstructured":"Azad RK, Shulaev V. Metabolomics technology and bioinformatics for precision medicine. Brief Bioinform. 2019;20(6):1957\u201371.","journal-title":"Brief Bioinform"},{"issue":"6","key":"3537_CR6","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1002\/mas.21562","volume":"37","author":"L Cui","year":"2018","unstructured":"Cui L, Lu H, Lee YH. Challenges and emergent solutions for LC-MS\/MS based untargeted metabolomics in diseases. Mass Spectrom Rev. 2018;37(6):772\u201392.","journal-title":"Mass Spectrom Rev"},{"issue":"6","key":"3537_CR7","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1002\/mas.21785","volume":"42","author":"CJ Chen","year":"2023","unstructured":"Chen CJ, Lee DY, Yu J, Lin YN, Lin TM. Recent advances in LC-MS-based metabolomics for clinical biomarker discovery. Mass Spectrom Rev. 2023;42(6):2349\u201378.","journal-title":"Mass Spectrom Rev"},{"issue":"1","key":"3537_CR8","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1186\/s12967-023-04604-7","volume":"21","author":"Y Yang","year":"2023","unstructured":"Yang Y, Wang Z, Li X, Lv J, Zhong R, Gao S, et al. Profiling the metabolic disorder and detection of colorectal cancer based on targeted amino acids metabolomics. J Transl Med. 2023;21(1):824.","journal-title":"J Transl Med"},{"issue":"1","key":"3537_CR9","doi-asserted-by":"publisher","first-page":"7802","DOI":"10.1038\/s41467-022-35511-y","volume":"13","author":"H Wang","year":"2022","unstructured":"Wang H, Jia H, Gao Y, Zhang H, Fan J, Zhang L, et al. Serum metabolic traits reveal therapeutic toxicities and responses of neoadjuvant chemoradiotherapy in patients with rectal cancer. Nat Commun. 2022;13(1):7802.","journal-title":"Nat Commun"},{"issue":"3","key":"3537_CR10","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.radonc.2018.06.022","volume":"128","author":"H Jia","year":"2018","unstructured":"Jia H, Shen X, Guan Y, Xu M, Tu J, Mo M, et al. Predicting the pathological response to neoadjuvant chemoradiation using untargeted metabolomics in locally advanced rectal cancer. Radiother Oncol. 2018;128(3):548\u201356.","journal-title":"Radiother Oncol"},{"issue":"36","key":"3537_CR11","doi-asserted-by":"publisher","first-page":"4231","DOI":"10.1200\/JCO.20.01932","volume":"38","author":"J Zhu","year":"2020","unstructured":"Zhu J, Liu A, Sun X, Liu L, Zhu Y, Zhang T, et al. Multicenter, Randomized, Phase III Trial of Neoadjuvant Chemoradiation With Capecitabine and Irinotecan Guided by UGT1A1 Status in Patients With Locally Advanced Rectal Cancer. J Clin Oncol. 2020;38(36):4231\u20139.","journal-title":"J Clin Oncol"},{"issue":"5","key":"3537_CR12","doi-asserted-by":"publisher","first-page":"e780","DOI":"10.1002\/onco.13707","volume":"26","author":"HY Chen","year":"2021","unstructured":"Chen HY, Feng LL, Li M, Ju HQ, Ding Y, Lan M, et al. College of American Pathologists Tumor Regression Grading System for Long-Term Outcome in Patients with Locally Advanced Rectal Cancer. Oncologist. 2021;26(5):e780\u201393.","journal-title":"Oncologist"},{"key":"3537_CR13","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.aca.2013.01.022","volume":"769","author":"J Boccard","year":"2013","unstructured":"Boccard J, Rutledge DN. A consensus orthogonal partial least squares discriminant analysis (OPLS-DA) strategy for multiblock Omics data fusion. Anal Chim Acta. 2013;769:30\u20139.","journal-title":"Anal Chim Acta"},{"issue":"1","key":"3537_CR14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.6026\/97320630002005","volume":"2","author":"L Kumar","year":"2007","unstructured":"Kumar L. Mfuzz: a software package for soft clustering of microarray data. Bioinformation. 2007;2(1):5\u20137.","journal-title":"Bioinformation"},{"issue":"D1","key":"3537_CR15","doi-asserted-by":"publisher","first-page":"D545","DOI":"10.1093\/nar\/gkaa970","volume":"49","author":"M Kanehisa","year":"2021","unstructured":"Kanehisa M, Furumichi M, Sato Y, Ishiguro-Watanabe M, Tanabe M. KEGG: integrating viruses and cellular organisms. Nucleic Acids Res. 2021;49(D1):D545\u201351.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"3537_CR16","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1002\/med.21658","volume":"40","author":"S Basith","year":"2020","unstructured":"Basith S, Manavalan B, Hwan Shin T, Lee G. Machine intelligence in peptide therapeutics: A next-generation tool for rapid disease screening. Med Res Rev. 2020;40(4):1276\u2013314.","journal-title":"Med Res Rev"},{"key":"3537_CR17","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12859-016-0900-5","volume":"17","author":"H Wang","year":"2016","unstructured":"Wang H, Yang F, Luo Z. An experimental study of the intrinsic stability of random forest variable importance measures. BMC Bioinformatics. 2016;17:60.","journal-title":"BMC Bioinformatics"},{"issue":"12","key":"3537_CR18","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s11306-022-01959-8","volume":"18","author":"J Lv","year":"2022","unstructured":"Lv J, Jia H, Mo M, Yuan J, Wu Z, Zhang S, et al. Changes of serum metabolites levels during neoadjuvant chemoradiation and prediction of the pathological response in locally advanced rectal cancer. Metabolomics. 2022;18(12):99.","journal-title":"Metabolomics"},{"key":"3537_CR19","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/bs.ircmb.2023.01.003","volume":"376","author":"M De Martino","year":"2023","unstructured":"De Martino M, Daviaud C, Hajjar E, Vanpouille-Box C. Fatty acid metabolism and radiation-induced anti-tumor immunity. Int Rev Cell Mol Biol. 2023;376:121\u201341.","journal-title":"Int Rev Cell Mol Biol"},{"issue":"3","key":"3537_CR20","doi-asserted-by":"publisher","first-page":"811","DOI":"10.7150\/ijbs.79928","volume":"19","author":"Y Yu","year":"2023","unstructured":"Yu Y, Yu J, Ge S, Su Y, Fan X. Novel insight into metabolic reprogrammming in cancer radioresistance: A promising therapeutic target in radiotherapy. Int J Biol Sci. 2023;19(3):811\u201328.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"3537_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2007.09.022","volume":"44","author":"KM Ahmed","year":"2008","unstructured":"Ahmed KM, Li JJ. NF-kappa B-mediated adaptive resistance to ionizing radiation. Free Radic Biol Med. 2008;44(1):1\u201313.","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"3537_CR22","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1080\/09553002.2020.1707325","volume":"96","author":"S Tang","year":"2020","unstructured":"Tang S, Li Z, Yang L, Shen L, Wang Y. A potential new role of ATM inhibitor in radiotherapy: suppressing ionizing Radiation-Activated EGFR. Int J Radiat Biol. 2020;96(4):461\u20138.","journal-title":"Int J Radiat Biol"},{"key":"3537_CR23","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/ijms23063375","volume":"23","author":"D Dakowicz","year":"2022","unstructured":"Dakowicz D, Zajkowska M, Mroczko B. Relationship between VEGF Family Members Their Receptors and Cell Death in the Neoplastic Transformation of Colorectal Cancer. Int J Mol Sci. 2022;23:6.","journal-title":"Int J Mol Sci"},{"issue":"Pt 2","key":"3537_CR24","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.semcancer.2022.04.003","volume":"86","author":"M Charpentier","year":"2022","unstructured":"Charpentier M, Spada S, Van Nest SJ, Demaria S. Radiation therapy-induced remodeling of the tumor immune microenvironment. Semin Cancer Biol. 2022;86(Pt 2):737\u201347.","journal-title":"Semin Cancer Biol"},{"key":"3537_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2021.101474","volume":"52","author":"M De Martino","year":"2021","unstructured":"De Martino M, Daviaud C, Vanpouille-Box C. Radiotherapy: An immune response modifier for immuno-oncology. Semin Immunol. 2021;52: 101474.","journal-title":"Semin Immunol"},{"issue":"9","key":"3537_CR26","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1002\/stem.3391","volume":"39","author":"M Ruckert","year":"2021","unstructured":"Ruckert M, Flohr AS, Hecht M, Gaipl US. Radiotherapy and the immune system: More than just immune suppression. Stem Cells. 2021;39(9):1155\u201365.","journal-title":"Stem Cells"},{"key":"3537_CR27","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/molecules27248691","volume":"27","author":"IB Verdaguer","year":"2022","unstructured":"Verdaguer IB, Crispim M, Hernandez A, Katzin AM. The Biomedical Importance of the Missing Pathway for Farnesol and Geranylgeraniol Salvage. Molecules. 2022;27:24.","journal-title":"Molecules"},{"issue":"3","key":"3537_CR28","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1080\/13543776.2020.1718653","volume":"30","author":"GA Delmondes","year":"2020","unstructured":"Delmondes GA, Santiago Lemos IC, Dias DQ, Cunha GLD, Araujo IM, Barbosa R, et al. Pharmacological applications of farnesol (C(15)H(26)O): a patent review. Expert Opin Ther Pat. 2020;30(3):227\u201334.","journal-title":"Expert Opin Ther Pat"},{"key":"3537_CR29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/molecules23112827","volume":"23","author":"YY Jung","year":"2018","unstructured":"Jung YY, Hwang ST, Sethi G, Fan L, Arfuso F, Ahn KS. Potential Anti-Inflammatory and Anti-Cancer Properties of Farnesol. Molecules. 2018;23:11.","journal-title":"Molecules"},{"key":"3537_CR30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/cancers14092183","volume":"14","author":"AH Janneh","year":"2022","unstructured":"Janneh AH, Ogretmen B. Targeting Sphingolipid Metabolism as a Therapeutic Strategy in Cancer Treatment. Cancers (Basel). 2022;14:9.","journal-title":"Cancers (Basel)."},{"issue":"1","key":"3537_CR31","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/ptr.7295","volume":"36","author":"Q Yuan","year":"2022","unstructured":"Yuan Q, Xie F, Huang W, Hu M, Yan Q, Chen Z, et al. The review of alpha-linolenic acid: Sources, metabolism, and pharmacology. Phytother Res. 2022;36(1):164\u201388.","journal-title":"Phytother Res"},{"issue":"3","key":"3537_CR32","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s10555-020-09904-8","volume":"39","author":"ML Edin","year":"2020","unstructured":"Edin ML, Duval C, Zhang G, Zeldin DC. Role of linoleic acid-derived oxylipins in cancer. Cancer Metastasis Rev. 2020;39(3):581\u20132.","journal-title":"Cancer Metastasis Rev"},{"issue":"27","key":"3537_CR33","doi-asserted-by":"publisher","first-page":"44893","DOI":"10.18632\/oncotarget.16488","volume":"8","author":"Q Peng","year":"2017","unstructured":"Peng Q, Zhang X, Min M, Zou L, Shen P, Zhu Y. The clinical role of microRNA-21 as a promising biomarker in the diagnosis and prognosis of colorectal cancer: a systematic review and meta-analysis. Oncotarget. 2017;8(27):44893\u2013909.","journal-title":"Oncotarget"},{"issue":"14","key":"3537_CR34","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.7150\/jca.30306","volume":"10","author":"Q Peng","year":"2019","unstructured":"Peng Q, Shen Y, Lin K, Zou L, Shen Y, Zhu Y. Identification of microRNA-92a and the related combination biomarkers as promising substrates in predicting risk, recurrence and poor survival of colorectal cancer. J Cancer. 2019;10(14):3154\u201371.","journal-title":"J Cancer"},{"key":"3537_CR35","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12935-019-0907-x","volume":"19","author":"Q Peng","year":"2019","unstructured":"Peng Q, Feng Z, Shen Y, Zhu J, Zou L, Shen Y, et al. Integrated analyses of microRNA-29 family and the related combination biomarkers demonstrate their widespread influence on risk, recurrence, metastasis and survival outcome in colorectal cancer. Cancer Cell Int. 2019;19:181.","journal-title":"Cancer Cell Int"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-024-03537-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-024-03537-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-024-03537-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T12:38:34Z","timestamp":1731587914000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-024-03537-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,3]]},"references-count":35,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3537"],"URL":"https:\/\/doi.org\/10.1007\/s12094-024-03537-x","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,3]]},"assertion":[{"value":"24 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No conflicts of interest relevant to this article were reported.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was reviewed and approved by the Ethics Committee of the Second Affiliated Hospital of Soochow University. Written informed consent was obtained from all participants involved in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}